Upfront cash payment $40M + up to 125M after achieving regulatory and sale based milestones. Tiered double digit royalties on net sales in licensed territories.
Time to buy
right, my numbers were down the road, 3-5 years! What it means if no b/o pp could be around $70 DOWN the road!
may I know your #s then? Bring your thoughts about it
without including Europe and Asia.
With expected 3M prescriptions sold x month @600 each, =1.800.000.000 monthly.
But John stated no ties on Sanofi deal, is it a clue for those waiting on b/o info?
Coming to Europe first half of 2016! No bad
patient cost prescription per month x 3 millones estimated patients market wow!
no ties to sanofi
going on its own
Or at relypsa website under investors link tab
Listen to @1410ET do not miss it!